SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950162-13-000066
Filing Date
2013-09-24
Accepted
2013-09-24 16:48:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFIANTE SCHEDULE 13D/A NO. 18 defiante13dano18_092413.htm SC 13D/A 250100
  Complete submission text file 0000950162-13-000066.txt   251709
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Subject) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-37889 | Film No.: 131112666
SIC: 2834 Pharmaceutical Preparations

Mailing Address RUA DOS FERREIROS,260 FUNCHAL MADEIRA S1 9000-082
Business Address
DEFIANTE FARMACEUTICA LDA (Filed by) CIK: 0001168857 (see all company filings)

Type: SC 13D/A